Notably, a multi-institutional effort to sequence metastatic, castration-resistant prostate cancer found that genomic alterations in the Wnt signaling pathway occur in approximately 18% of cases, and these included alterations in adenomatous polyposis coli (Apc), an endogenous inhibitor of Wnt signaling [3]. This evidence concerns the gene APC and prostate cancer.